Orthopaedic & Rheumatologic Institute Outcomes
Surgical Quality Improvement
Total Knee Arthroplasty Outcomes
Total Knee Arthroplasty ACS NSQIP Outcomes
January 1, 2023 – December 31, 2023
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall total knee arthroplasty ACS NSQIP performance benchmarked against 472 participating sites.
| Total Knee Arthroplasty (472 sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 310 | 2.90% | 4.25% |
| Cardiac | 310 | 0.65% | 0.27% |
| Unplanned Intubation | 310 | 0.00% | 0.13% |
| Ventilator > 48 Hours | 310 | 0.00% | 0.04% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolusᵃ | 310 | 2.58% | 0.91% |
| Renal Failure | 310 | 0.65% | 0.19% |
| Urinary Tract Infection (UTI) | 310 | 0.00% | 0.70% |
| Surgical Site Infection (SSI) | 310 | 1.29% | 1.79% |
| Sepsis | 310 | 0.00% | 0.41% |
| Unplanned Reoperation | 310 | 0.65% | 1.32% |
| Unplanned Readmission | 310 | 5.16% | 4.39% |
American College of Surgeons National Surgical Quality Improvement Program, 2024.
ACS NSQIP® Semiannual Report July 8, 2024, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.
